RIGL: Rigel Pharmaceuticals Inc Sotuvga nisbatan narx
Hematologiya mahsulotlaridan tushadigan barqaror daromad Rigel Pharmaceuticals (RIGL) kompaniyasining onkologiya bo'yicha R&D va distributsiyasini moliyalashtiradi. Sotuvlar nisbatidagi narx koeffitsienti joriy dinamikani aks ettiradi, bunda 3.00 ushbu metrikaning haqiqiy qiymatini ko'rsatadi. Jamoa dori vositalarining tijoratga chiqarilishi va premium imtiyozlar paketiga e'tibor qaratgan. Qon va immunitet bo'yicha ekspertlarni jalb qilish ilmiy tadqiqotlarni qo'llab-quvvatlash va raqobatbardosh kompensatsiyaga asoslangan.
Rigel Pharmaceuticals Inc (RIGL) kompaniyasining tahliliy kesimlari
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Qarzning kapitalga nisbati Rigel Pharmaceuticals|RIGL - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Rigel Corp|RIGL - Kompaniya qarzlari|Qarzning balans kapitallashuviga nisbati Rigel Pharmaceuticals Inc|RIGL - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Rigel Pharmaceuticals|Kritik likvidlik koeffitsiyenti rigel.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
RIGL - Sof foyda|Kutilayotgan sof daromad Rigel Pharmaceuticals|RIGL - P/E multiplikatori|Forvard P/E multiplikatori Rigel Pharma|RIGL - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Rigel Pharmaceuticals Inc|RIGL - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun sof foyda Rigel Pharmaceuticals|RIGL - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi rigel.com|RIGL - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Rigel Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning fundamental tahlili:rigel.com RIGL
P/S koeffitsiyenti bozor kapitalizatsiyasini savdo hajmi bilan solishtirib, daromadning har bir birligi qiymatiga nisbatan investorlar kayfiyatining o'zgarishini real vaqt rejimida baholash imkonini beradi. Ushbu narx-savdo ko'rsatkichi biznesning haddan tashqari qimmat yoki past baholanganligini aniqlash imkonini beradi, bu esa Rigel Pharmaceuticals (RIGL) uchun uning onkologiya portfelini tijoriy kengaytirish va operatsion daromadlilikka o'tish davrida juda muhimdir.
Rigel Pharmaceuticals kimlar bilan raqobatlashadi
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati PTGX (Protagonist Corp)|IMVT: P/S multiplikatori|KNSA - Narx/daromad koeffitsiyenti|GRFS (Grifols) - P/S multiplikatori|ADPT - Narx/daromad multiplikatori|P/S multiplikatori CLDX|AUPH - Sotuvga nisbatan narx|Narxning daromadga nisbati BioCryst BCRX|veratx.com - Narxning daromadga nisbati|DNTH: Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati PHVS (Pharvaris NV)|AbCellera Biologics Inc (ABCL) - Narxning daromadga nisbati|Narxning sotuvga nisbati TRML (Tourmaline)|PGEN (Precigen, Inc.) - P/S multiplikatori|PHAR: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori NKTR|P/S multiplikatori Upstream Bio, Inc. (UPB)|Narxning daromadga nisbati Zenas Biopharma, Inc. ZBIO|Bozor kapitallashuvining daromadga nisbati IMNM|GOSS - Narxning daromadga nisbati|kalvista.com (KALV) - Kapitalizatsiyaning daromadga nisbati|SEPN: P/S multiplikatori|Pieris Pharma (PVLA) - P/S multiplikatori|SVRA (Savara Corp) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati AnaptysBio Inc. (ANAB)|P/S multiplikatori ATXS|ENGN - Sotuvga nisbatan narx|RAPT Therapeutics - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Aerovate Therapeutics, Inc. JBIO|ACRS: Kapitalizatsiyaning daromadga nisbati|Kyverna Therapeutics, Inc - Kapitalizatsiyaning sotish hajmiga nisbati|TLSA: P/S multiplikatori|CABA - Narx/daromad koeffitsiyenti|VTYX (Ventyx Biosciences, Inc.) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Theratechnologies, Inc. (THTX)|P/S multiplikatori AVTX|P/S multiplikatori Eledon Pharmaceuticals, Inc (ELDN)|Narxning daromadga nisbati Agenus AGEN|climbbio.com - Narxning daromadga nisbati|ZURA - Narxning daromadga nisbati|Narx/daromad koeffitsiyenti aTyr Pharma Inc ATYR|adagene.com (ADAG) - Narxning daromadga nisbati|Ikena Oncology - Bozor kapitallashuvining daromadga nisbati|STTK (Shattuck Labs Inc) - P/S multiplikatori|Equillium Bio (EQ) - Narx/daromad koeffitsiyenti|P/S multiplikatori CNTB|immunic-therapeutics.com (IMUX) - Narx/daromad multiplikatori|Narxning daromadga nisbati Atara Bio ATRA|InflaRx NV - Narxning daromadga nisbati|XFOR - Narxning daromadga nisbati|Narxning sotuvga nisbati ACET|CELU: P/S multiplikatori|INmune Bio Inc - Bozor kapitallashuvining daromadga nisbati|BRNS (Barinthus Bio) - P/S multiplikatori|P/S multiplikatori Kezar Life Sciences Inc|Narxning daromadga nisbati SAB Biotherapeutics (SABS)|AKTX (akaritx.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Enlivex Therapeutics Ltd. ENLV|QTTB - Kapitalizatsiyaning daromadga nisbati|GeoVax Labs Inc - P/S multiplikatori|EDSA - P/S multiplikatori|IBIO (iBio, Inc.) - Kapitalizatsiyaning daromadga nisbati|Carisma Therapeutics Inc. - Bozor kapitallashuvining daromadga nisbati|XTLB (XTL Biopharmaceuticals Ltd.) - P/S multiplikatori|Bolt Bio (BOLT) - Narx/daromad koeffitsiyenti|Narxning daromadga nisbati HCW Biologics Inc. (HCWB)|Kapitalizatsiyaning daromadga nisbati aptevotherapeutics.com APVO|Narxning daromadga nisbati AIM ImmunoTech Inc. AIM|ADTX - Kapitalizatsiyaning daromadga nisbati|GRI: Kapitalizatsiyaning daromadga nisbati|XRTX - P/S multiplikatori|ReShape Lifesciences (HIND) - Narxning daromadga nisbati|Kapitalizatsiya va daromad nisbati REVB|INDP (Indaptus Therapeutics) - P/S multiplikatori|Sotuvga nisbatan narx scinai.com SCNI|Narxning daromadga nisbati CalciMedica, Inc. (CALI)|AFMD (affimed.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ALLK (Allakos)|Narx/daromad koeffitsiyenti HOOKIPA Pharma, Inc. (HOOK)|IGM Bio - P/S multiplikatori|Narx/daromad multiplikatori iteostherapeutics.com (ITOS)|OCEA: P/S multiplikatori|Sotuvga nisbatan narx TC BioPharm (Holdings) Plc (TCBP)|Narxning daromadga nisbati Third Harmonic Bio, Inc
